Skip to Main Content

As demand grows for faster drug approvals, a new study suggests watching for a concerning side effect: medicines that were approved using expedited regulatory procedures had a 38 percent higher rate of changes to safety warnings on product labels.

The analysis also found that there was a 48 percent higher rate of changes to the two most important types of warnings — so-called black boxes, which are designed to call attention to serious or life-threatening risk, and contraindications, which refers to a risk outweighing a benefit.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.